Welcome to LookChem.com Sign In|Join Free
  • or
6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester is a chemical compound with the molecular formula C11H14N2O2, belonging to the class of pyridinecarboxylic acids. It features a pyridine ring substituted with an ethylamino group and a carboxylic acid methyl ester, and is commonly utilized in medicinal chemistry for the synthesis of drugs and pharmaceutical products. 6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester may exhibit various biological activities, and ongoing research is exploring its potential applications in the medical field.

177759-45-4

Post Buying Request

177759-45-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

177759-45-4 Usage

Uses

Used in Pharmaceutical Industry:
6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester is used as a key intermediate in the synthesis of various drugs and pharmaceutical products. Its unique chemical structure allows for the development of new therapeutic agents with potential applications in treating a range of medical conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester is used as a starting material or building block for the design and synthesis of novel compounds with potential biological activities. Researchers are investigating its properties to understand its interactions with biological targets and explore its potential use in the development of new drugs.
Used in Drug Discovery:
6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester is employed in drug discovery processes to identify and optimize compounds with therapeutic potential. Its unique chemical features make it a valuable tool for the development of new pharmaceutical agents that can address unmet medical needs.
Used in Drug Development:
As a component of drug development pipelines, 6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester is used to create and test new drug candidates. Its incorporation into various chemical entities allows researchers to evaluate its efficacy, safety, and pharmacokinetic properties in preclinical and clinical studies.
Used in Drug Synthesis:
6-(Ethylamino)-3-pyridinecarboxylic acid methyl ester is utilized in the synthesis of complex drug molecules, where its reactivity and functional groups can be exploited to form new chemical bonds and structures. This enables the creation of innovative pharmaceutical compounds with improved therapeutic profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 177759-45-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,7,5 and 9 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 177759-45:
(8*1)+(7*7)+(6*7)+(5*7)+(4*5)+(3*9)+(2*4)+(1*5)=194
194 % 10 = 4
So 177759-45-4 is a valid CAS Registry Number.

177759-45-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 6-(ethylamino)nicotinate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:177759-45-4 SDS

177759-45-4Relevant academic research and scientific papers

TETRA-AZA-HETEROCYCLES AS PHOSPHATIDYLINOSITOL-3-KINASES (PI3-KINASES) INHIBITOR

-

Page/Page column 15, (2010/04/30)

The present invention encompasses compounds of general formula (1) wherein R1 to R4, A, X, m and k are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation,

THIA-TRIAZA-AS-INDACENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER

-

Page/Page column 17, (2010/11/05)

The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the

THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER

-

Page/Page column 16, (2010/11/05)

The present invention encompasses compounds of general formula (1) wherein 5 R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and th

THIAZOLYL-DIHYDRO-INDAZOLES

-

Page/Page column 23; 24, (2009/10/22)

The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 177759-45-4